, Neuromedin U , OSM , OSMRβ , Oncostatin M , Oncostatin-M specific receptor subunit beta , PAR2 , PC (20) , PN , Protease activated receptor 2 , Provocative concentration causing a 20% drop in forced expiratory

Dr. GPCR Podcast << Back to podcast list Dr. Jennifer Pluznick About this episode Dr. Pluznick discovered that olfactory receptors in mice are also expressed in their kidneys and blood vessels. Her research is focused on the role of chemosensory GPCRs in regulating renal and cardiovascular function, and identifying renal/cardiovascular olfactory receptor ligands, and relating them to whole-animal physiology. This work contributes to a better understanding of how the kidney helps maintain homeostasis in humans. Jennifer is currently an assistant professor of physiology at the Johns Hopkins School of Medicine. She received her undergraduate degree in biology from Truman State University and earned her Ph.D. in renal physiology from the University of Nebraska Medical Center. She then spent five years training as a postdoctoral fellow in the laboratory of Michael Caplan at Yale University, where she studied both renal physiology and sensory biology systems and focused on olfaction. Dr. Jennifer Pluznick on the web John Hopkins Pluznick Lab Pubmed Ted Talk Dr. GPCR Ecosystem Thanks for listening to this podcast episode This short survey will help us understand your needs to bring you exciting and informative content; this short survey should take 5 minutes to fill. Listen and subscribe to where you get your podcasts. << Previous Podcast Episode Next Podcast Episode >>

Even though Maria stumbled upon the GPCR field, her 20 years in both academia and in the industry working

He has 20+ years of experience in in vitro and in vivo GPCR pharmacology and has published seminal papers

David has over 20+ years of experience working in a drug discovery environment mainly in a specialist

Degrade the Constitutively Active Onco-GPCR in Uveal Melanoma Date & Time Friday, November 3rd / 4:20

Cannabinoid compounds to augment L-DOPA treatment in Parkinson's Disease Date & Time Friday, November 3rd / 9:20

Date Time Title October 23, 2024 October 24, 2024 October 25, 2024 *Flash Presentations: 10 min *Talks 20

expertise in profiling receptor binding and function at the molecular and cellular levels over the last 20

Mechanism for Microbiota Effects on the Immune System, and Western Diseases Published date November 20

McGill along the dopamine circuit Bruno Giros McGill University Read More Friday, November 3rd / 9:20 Vulnerability in Ovarian Cancer Robert Rottapel University of Toronto Read More Friday, November 3rd / 4:20

Trejo has been continuously funded by the NIH for >20 years and was a recipient of the prestigious American

Demet shared that they have been working on the Latrophilin project since 2013, screening about 20 adhesion

signaling and function NovoiSMART - A new platform for GPCR antibody drug discovery Gavin Zhang Read More 3:20

and shall not affect the validity and enforceability of the remaining provisions of the agreement. ​ 20